Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 404 results for "clinigene"

Clinigen launches global access program for Clovis' rociletinib

UK specialty pharmaceutical and services company Clinigen has started a global access program in Europe… In order to access this content you need to be logged into the site and have an active subscription or trial subscription. Please login , ... Pharma Letter, 7 hours ago
[x]  

8 images for clinigene

SleekMoney, 3 weeks ago
Palestine Telegraph, 3 weeks ago
Proactive Investors.co.uk, 3 weeks ago
East Midlands Business Link, 4 weeks ago
This is Money, 3 weeks ago
Proactive Investors.co.uk, 4 weeks ago
Proactive Investors.co.uk, 4 weeks ago
Yahoo! UK and Ireland, 4 weeks ago

Clinigen Group acquires Idis Group Holdings

Clinigen Group plc, a specialty pharmaceuticals and services company, has acquired Idis Group Holdings Limited, a pharmaceutical services company, from CBPE Capital LLP, a private equity firm, for an enterprise value of GBP225 million. Both the ...
 Individual.com4 weeks ago Clinigen Group plc to acquire Idis Group Holdings Ltd  Reuters1 month ago

CBPE Capital sells Idis Group Holdings to Clinigen Group

CBPE Capital LLP, a private equity firm, has sold its stake in Idis Group Holdings Limited, a pharmaceutical services company, to Clinigen Group plc, a specialty pharmaceuticals and services company, for an enterprise value of GBP225 million. Both ...
 Individual.com4 weeks ago

Clinigen Group Closes Acquisition of Unlicensed Medicine Supplier Idis

- UK-based specialty pharmaceutical company Clinigen Group plc (AIM: CLIN) has completed the acquisition of Idis Group Holdings Ltd., the company said on Wednesday. As a result of the completion of the acquisition, 27m new ordinary shares in the ...
 Bloomberg4 weeks ago Clinigen to Acquire Unlicensed Medicines Company Idis  PredictWallStreet1 month ago

Clinigen set to lead unlicensed drugs market

The Financial Times Ltd 2015 FT and 'Financial Times' are trademarks of The Financial Times Ltd. SHARE THIS QUOTE Tweet this quote Printed from: http://www.ft.com/cms/s/0/c7fa0d9a-ead8-11e4-96ec-00144feab7de.html Print a single copy of this article ...
 Austin American Statesman1 month ago Clinigen set to lead multibillion-dollar unlicensed drugs market  FirstWord Pharma1 month ago
Yahoo! UK and Ireland

Why Shares In Clinigen Group PLC Jumped More Than 10% Today

Clinigen (LSE: CLIN), the speciality pharmaceutical company, surged more than 10% in early trade today after the company announced that it has agreed to acquire Idis Group Holdings Limited. The deal will create a market leader in the market for the ...
 Yahoo! UK and Ireland1 month ago

BRIEF-Clinigen Group agrees to buy Idis for 225 million pounds

April 24 (Reuters) - Clinigen Group Plc * £225 million acquisition of idis and £135 million vendor placing Source text for Eikon: Further
 Reuters UK1 month ago

Broker spotlight, including Bwin.party, 888 Holdings, Royal Mail Group, BHP Billiton, Ergomed, Clinigen ...

Goldman Sachs has stuck with its conviction buy easyJet (), despite the mixed outlook the airline revealed last week. EasyJet is taking market share from retrenching rivals such as Air France while a lower oil price will both raise consumer ...
 Proactive Investors.co.uk1 week ago Broker spotlight including Bwin.party 888 Holdings Royal Mail Group BHP Billiton Ergomed Clinigen ...  MENAFN1 week ago

Merger creates biggest supplier of unlicensed drugs

Speciality pharma company Clinigen is to buy its rival Idis , making it the market leader in ethical unlicensed drug supply. UK-based Clinigen agreed a price of £225 million in late April. This is a good fit, says Mick Cooper, head of health ...
 RSC3 weeks ago Clinigen now global leader in unlicensed medicines after Idis deal  Proactive Investors.co.uk1 month ago Clinigen moves into unlicensed drugs supply with Idis deal  London South East1 month ago REUTERS - Clinigen moves into unlicensed drugs supply with Idis deal  Namibia Press Agency1 month ago
[x]  

Clinigen raises £135 million for acquisition

The Clinigen Group Plc, a specialty pharmaceutical company, successfully raised £135 million in late April to finance its £225 million acquisition of Idis Group Holdings Ltd, a supplier of unlicensed medicines to the hospital market. Location ...
 MedNous3 weeks ago Clinigen Group plc Completion of Acquisition of Idis  ADVFN UK4 weeks ago Clinigen (#CLIN) announces £225m purchase of IDIS and a £135m vendorplacing  Share Prophets1 month ago Clinigen Group plc £225M Acquisition of Idis; £135m Vendor Placing  ADVFN UK1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less